LPTX - Leap Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

28.7M

Cash

54.92M

Avg Qtr Burn

-11.64M

Short % of Float

4.25%

Insider Ownership

14.13%

Institutional Own.

34.21%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DKN-01 (+/- Paclitaxel) Details Cancer, Carcinosarcoma, Ovarian cancer, Endometrial cancer	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DKN-01 (Bevacizumab & Chemotherapy) Details Esophageal cancer, Cancer, Colorectal cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DKN-01 + pembrolizumab Details Endometrial cancer, Cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DKN-01 (+ tislelizumab +/- CAPOX) Details Gastroesophageal junction tumors, Cancer, Gastric cancer	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FL-301 Details Cancer, Pancreatic cancer, Gastric cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DKN-01 monotherapy or in combination with docetaxel Details Prostate cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.